Investorideas.com newswire, breaking news for marijuana, cannabis and hemp stocks

Loading...

Wednesday 3 June 2020

Investorideas.com - Breaking Cannabis Stock News: FSD Pharma (NASDAQ: $HUGE) (CSE: $HUGE.C) Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis

Investorideas.com - Breaking Cannabis Stock News: FSD Pharma (NASDAQ: $HUGE) (CSE: $HUGE.C) Receives U.S. FDA Approval to design a Phase 2a Clinical Trial to Treat Patients with Suspected or Confirmed COVID-19 Diagnosis
-

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB)

You can't hold a good weed stock down (Nasdaq: CGC) (NASDAQ: TLRY) (NASDAQ: ACB) : You can't hold a good weed stock down (Nasdaq: CG...